2,3- diphosphoglycerate
Showing 1 - 25 of >10,000
Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic
Completed
- CLL
-
Tampere, FinlandTampere university Hospital
Feb 22, 2022
Oxygen Dissociation Curve in Patients Undergoing Orthotopic
Not yet recruiting
- Liver Transplantation
- Assessment of Oxygen Dissociation Curve (ODC)
-
Innsbruck, Tyrol, AustriaMedical University Innsbruck
Apr 19, 2023
2,3-Bisphosphoglycerate Trial (remote ischemic conditioning)
Unknown status
- 2,3-Bisphosphoglycerate
- remote ischemic conditioning
- (no location specified)
Nov 29, 2020
Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)
Enrolling by invitation
- Breast Cancer Female
-
Tomsk, Russian FederationOlga
Jun 19, 2023
Febrile Illness Trial (Connex CSVM with Timmy3 module)
Not yet recruiting
- Febrile Illness
- Connex CSVM with Timmy3 module
- (no location specified)
Sep 25, 2023
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Nicotine Use Disorder Trial (E-liquid coolant (no WS-3) (1), E-liquid coolant (Low WS-3) (1), E-liquid coolant (High WS-3) (1))
Not yet recruiting
- Nicotine Use Disorder
- E-liquid coolant (no WS-3) (1)
- +8 more
- (no location specified)
Jul 7, 2023
3T MRI T2 Mapping Technique in Chondro-labral Pathology of Hip,
Not yet recruiting
- Hip Injuries and Disorders
- Hip Arthrosis
- T2 mapping 3T MRI + hip arthroscopy
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Sep 28, 2023
People Who Have Genetic Changes and Features of Autism: Simons
Recruiting
- 16P11.2 Deletion Syndrome
- +184 more
-
New York, New York
- +1 more
Jan 6, 2023
COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))
Completed
- COVID-19
- hAd5-S-Fusion+N-ETSD
- Placebo (0.9% (w/v) saline)
-
Newport Beach, CaliforniaHoag Memorial Hospital Presbyterian
Sep 1, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Diabetes Trial in Seongnam-si (BR3006-1, BR3006-2, BR3006-3)
Not yet recruiting
- Diabetes Mellitus
- BR3006-1
- +2 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center(CBMC)
Jul 17, 2023
Alveolar Ridge Preservation Trial in Taoyuan (procedure, drug, other)
Not yet recruiting
- Alveolar Ridge Preservation
- Autologous Tooth Root
- +2 more
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Nov 15, 2023
HER-2 Positive Advanced Solid Tumors Trial (D3L-001)
Not yet recruiting
- HER-2 Positive Advanced Solid Tumors
- D3L-001
- (no location specified)
Jul 20, 2023
Aging Trial in Glendale
Withdrawn
- Aging
- (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
- Control
-
Glendale, ArizonaGlencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023
Stellate Ganglion, Radiofrequency Ablation, Complex Regional Pain Syndromes Trial in Cairo (Radiofrequency stellate ganglion
Not yet recruiting
- Stellate Ganglion
- +3 more
- Radiofrequency stellate ganglion block using ultrasound guidance (SGB)
- +2 more
-
Cairo, EgyptNational Cancer Institute
Sep 5, 2023
T2DM (Type 2 Diabetes) Trial (DWP16001 0.3 mg)
Not yet recruiting
- T2DM (Type 2 Diabetes Mellitus)
- DWP16001 0.3 mg
- (no location specified)
Nov 15, 2023
Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3
Recruiting
- Immunization
- +2 more
- 9-valent HPV vaccine, 2 dose efficacy
- 9-valent HPV vaccine, 3 doses standard timing
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 30, 2023
Asthma in Children Trial (JOE)
Not yet recruiting
- Asthma in Children
- JOE
- (no location specified)
Aug 23, 2022
Influenza, Human, Infections, Respiratory Tract Infections Trial in Philippines, United States (Low dose A/H2N3c + standard dose
Not yet recruiting
- Influenza, Human
- +4 more
- Low dose A/H2N3c + standard dose MF59
- +5 more
-
Rockville, Maryland
- +7 more
May 26, 2023
Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty
Completed
- Type 2 Diabetes Mellitus
- +2 more
- omega-3 polyunsaturated fatty acids
- corn oil
-
Lianshui, Jiangsu, ChinaLian Shui People's Hospital
Oct 2, 2023
Esophageal Squamous Carcinoma, HER-2 Protein Overexpression Trial (RC48+PD-1+platinum-based)
Not yet recruiting
- Esophageal Squamous Carcinoma
- HER-2 Protein Overexpression
- (no location specified)
Sep 24, 2023
Concussion, Mild Trial in Winnipeg (Omega-3, Placebo)
Not yet recruiting
- Concussion, Mild
- Omega-3
- Placebo
-
Winnipeg, Manitoba, CanadaApplied Research Centre, Faculty of Kinesiology, University of M
Apr 27, 2023
Mandible Tumor Trial in Tanta (Mandibular marginal resection and reconstruction, mandibular osteosynthesis a 2.3mm
Enrolling by invitation
- Mandible Tumor
- Mandibular marginal resection and reconstruction
- mandibular osteosynthesis a 2.3mm reconstruction bone plate
-
Tanta, Gharbia, EgyptTanta University
Oct 19, 2023